The plant-derived hallucinogen, salvinorin A, produces κ-opioid agonist-like discriminative effects in rhesus monkeys
@article{Butelman2004ThePH, title={The plant-derived hallucinogen, salvinorin A, produces $\kappa$-opioid agonist-like discriminative effects in rhesus monkeys}, author={Eduardo R Butelman and Todd J. Harris and Mary Jeanne Kreek}, journal={Psychopharmacology}, year={2004}, volume={172}, pages={220-224} }
RationaleSalvinorin A is the active component of the hallucinogenic plant Salvia divinorum. The potential mode of action of this hallucinogen was unknown until recently. A recent in vitro study detected high affinity and efficacy of salvinorin A at κ-opioid receptors. It was postulated that salvinorin A would produce discriminative stimulus effects similar to those of a high efficacy κ-agonist (U69,593) in rhesus monkeys.MethodsMonkeys were previously trained to discriminate U69,593 (0.0056 or…
106 Citations
The hallucinogen derived from Salvia divinorum, salvinorin A, has κ-opioid agonist discriminative stimulus effects in rats
- Biology, PsychologyNeuropharmacology
- 2007
The discriminative effects of the κ-opioid hallucinogen salvinorin A in nonhuman primates: dissociation from classic hallucinogen effects
- Biology, PsychologyPsychopharmacology
- 2009
These findings support the conclusion that the interoceptive/discriminative cue produced by salvinorin A is mediated by agonism at κ-receptors and is mechanistically distinct from that produced by a classic serotonergic hallucinogen.
Unconditioned Behavioral Effects of the Powerful κ-Opioid Hallucinogen Salvinorin A in Nonhuman Primates: Fast Onset and Entry into Cerebrospinal Fluid
- Biology, PsychologyJournal of Pharmacology and Experimental Therapeutics
- 2009
These are the first studies documenting rapid unconditioned effects of salvinorin A in a primate species, consistent with descriptive reports of rapid and robust effects of this powerful hallucinogen in humans.
Effects of Salvinorin A, a κ-Opioid Hallucinogen, on a Neuroendocrine Biomarker Assay in Nonhuman Primates with High κ-Receptor Homology to Humans
- Biology, ChemistryJournal of Pharmacology and Experimental Therapeutics
- 2007
It is indicated that the hallucinogen salvinorin A acts as a high-efficacy κ-agonist in nonhuman primates in a translationally viable neuroendocrine biomarker assay, including particular C-terminal residues thought to be involved in receptor desensitization and internalization.
Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69,593 and U50,488 in rats
- Biology, PsychologyPsychopharmacology
- 2008
These findings support previous reports indicating that the discriminative stimulus effects of salvinorin A are mediated by kappa receptors, and future studies may assist in the development and screening of salvinegorin A analogs for potential pharmacotherapy.
Kappa-opioid receptor-mediated effects of the plant-derived hallucinogen, salvinorin A, on inverted screen performance in the mouse
- Biology, ChemistryBehavioural pharmacology
- 2005
In the mouse, salvinorin A disrupted climbing behavior on an inverted screen task, indicating a rapid, but short-lived induction of sedation/motor incoordination and the possibility that the development of other diterpene-based opioids may yield important therapeutic compounds.
Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodents
- Biology, ChemistryPsychopharmacology
- 2010
These findings suggest that similarities in the pharmacological effects of salvinorin A and those of cannabinoids are mediated by its activation of KOR rather than by any direct action of salvia divinorum A on the endocannabinoid system.
Hallucinatory and rewarding effect of salvinorin A in zebrafish: κ-opioid and CB1-cannabinoid receptor involvement
- Biology, PsychologyPsychopharmacology
- 2006
Results indicate that salvinorin A, as is sometimes reported in humans, exhibits rewarding effects, independently from its motor activity, suggesting the usefulness of the zebrafish model to study addictive behavior.
Involvement of κ-Opioid and Endocannabinoid System on Salvinorin A-Induced Reward
- Biology, MedicineBiological Psychiatry
- 2008
References
SHOWING 1-10 OF 20 REFERENCES
Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist
- BiologyProceedings of the National Academy of Sciences of the United States of America
- 2002
Salvinorin A is the first naturally occurring nonnitrogenous opioid-receptor subtype-selective agonist for κ opioid receptors and may represent novel psychotherapeutic compounds for diseases manifested by perceptual distortions (e.g., schizophrenia, dementia, and bipolar disorders).
Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.
- Biology, PsychologyProceedings of the National Academy of Sciences of the United States of America
- 2002
Salvinorin A is the first naturally occurring nonnitrogenous opioid-receptor subtype-selective agonist for kappa opioid receptors, and may represent novel psychotherapeutic compounds for diseases manifested by perceptual distortions (e.g., schizophrenia, dementia, and bipolar disorders).
Kappa opioid antagonist effects of the novel kappa antagonist 5′-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys
- Biology, PsychologyPsychopharmacology
- 2002
Results suggest that 5′-Guanidinonaltrindole is a potent and selective kappa antagonist with a slow onset and long duration of action in rhesus monkeys.
Salvia divinorum and the unique diterpene hallucinogen, Salvinorin (divinorin) A.
- ChemistryJournal of psychoactive drugs
- 1994
Salvia divinorum is a vision-inducing mint used by the Mazatec people of Oaxaca, Mexico. It is grown in California and other parts of the United States where it is employed as a legal hallucinogen.…
Peripheral selectivity and apparent efficacy of dynorphins: comparison to non-peptidic κ-opioid agonists in rhesus monkeys
- Biology, ChemistryPsychoneuroendocrinology
- 2004
Salvinorin A: the "magic mint" hallucinogen finds a molecular target in the kappa opioid receptor.
- Chemistry, BiologyTrends in pharmacological sciences
- 2003
Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans
- Medicine, PsychologyPsychopharmacology
- 2001
The pharmacodynamic effects of enadoline significantly increased measures of sedation, confusion and dizziness, produced visual distortions and feelings of depersonalization, and increased urinary output, and the highest dose was not tolerated and led to psychotomimetic effects.
Comparison of the discriminative and neuroendocrine effects of centrally penetrating κ-opioid agonists in rhesus monkeys
- Biology, MedicinePsychopharmacology
- 2002
The potency of centrally penetrating κ-agonists in causing their neuroendocrine effects is similar to their potency in causing discriminative effects, as compared to fentanyl, nalbuphine and SNC80.
Salvia divinorum: an hallucinogenic mint which might become a new recreational drug in Switzerland.
- ChemistryForensic science international
- 2000
Effects of systemically administered dynorphin A(1-17) in rhesus monkeys.
- Biology, MedicineThe Journal of pharmacology and experimental therapeutics
- 1999
Serum prolactin levels are a sensitive quantitative endpoint to study the systemic effects of the endogenous opioid peptide, dynorphin A(1-17), in primates and are shown to be consistent with opioid receptor mediation.